BRAF and cancer: RKIP is known to associate with both Raf-1 and B-Raf isoforms (Trakul et al., 2005) and has been shown to inhibit B-Raf activation in cancer cells (Park et al., 2005) as well as the strong interaction with Raf-1 previously mentioned.